BIOMAT Database Logo BIOMAT Database Logo

Hepatorenal syndrome: resolution after transjugular intrahepatic portosystemic shunt. 1995

T M Sturgis
Department of Medicine, School of Medicine, East Carolina University, Greenville, NC 27834-4354, USA.

Hepatorenal syndrome (HRS), a functional renal failure associated with severe liver disease, is believed to result from diminished effective arterial volume and altered renal hemodynamics. Death is almost inevitable after its development and therapeutic options are limited. Surgical shunts carry an increase in morbidity and mortality, and peritoneovenous shunts are frequently complicated by infection and coagulopathy. We report a case of hepatorenal syndrome successfully treated with transjugular intrahepatic portosystemic shunt (TIPS). This is an unusual therapeutic option for HRS and may lead to future indications for TIPS.

UI MeSH Term Description Entries
D008297 Male Males
D011170 Portasystemic Shunt, Surgical Surgical venous shunt between the portal and systemic circulation to effect decompression of the portal circulation. It is performed primarily in the treatment of bleeding esophageal varices resulting from portal hypertension. Types of shunt include portacaval, splenorenal, mesocaval, splenocaval, left gastric-caval (coronary-caval), portarenal, umbilicorenal, and umbilicocaval. Portosystemic Shunt, Surgical,Portasystemic Shunt,Portosystemic Shunt,Shunt, Surgical Portasystemic,Shunt, Surgical Portosystemic,Surgical Portasystemic Shunt,Surgical Portosystemic Shunt,Portasystemic Shunts,Portasystemic Shunts, Surgical,Portosystemic Shunts,Portosystemic Shunts, Surgical,Shunt, Portasystemic,Shunt, Portosystemic,Shunts, Portasystemic,Shunts, Portosystemic,Shunts, Surgical Portasystemic,Shunts, Surgical Portosystemic,Surgical Portasystemic Shunts,Surgical Portosystemic Shunts
D004932 Esophageal and Gastric Varices Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL). Esophageal Varices,Gastric Varices,Esophageal Varix,Gastric Varix,Varices, Esophageal,Varices, Gastric,Varix, Esophageal,Varix, Gastric
D006530 Hepatorenal Syndrome Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention. Syndrome, Hepatorenal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015607 Stents Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting. Stent
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

T M Sturgis
Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome.
March 1997, Lancet (London, England),
T M Sturgis
Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt.
July 1995, The American journal of gastroenterology,
T M Sturgis
Transjugular intrahepatic portosystemic stent shunt for hepatorenal syndrome and ascites.
July 1998, Digestion,
T M Sturgis
Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
November 2006, European journal of gastroenterology & hepatology,
T M Sturgis
Radiodermatitis after transjugular intrahepatic portosystemic shunt.
March 1997, Southern medical journal,
T M Sturgis
Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.
April 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
T M Sturgis
Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients.
November 2020, Digestive diseases and sciences,
T M Sturgis
[Transjugular intrahepatic portosystemic shunt].
January 1993, Cor et vasa,
T M Sturgis
Transjugular intrahepatic portosystemic shunt.
January 1994, Romanian journal of internal medicine = Revue roumaine de medecine interne,
T M Sturgis
Transjugular intrahepatic portosystemic shunt.
February 2004, Clinical privilege white paper,
Copied contents to your clipboard!